Semler Scientific (NASDAQ:SMLR) Stock Price Down 6.1% – Should You Sell?

Semler Scientific, Inc. (NASDAQ:SMLR)’s share price fell 6.1% during mid-day trading on Tuesday . The company traded as low as $54.74 and last traded at $55.36. Approximately 133,518 shares traded hands during trading, a decline of 63% from the average daily volume of 359,435 shares. The stock had previously closed at $58.94.

Semler Scientific Trading Down 9.1 %

The company’s fifty day simple moving average is $55.94 and its 200 day simple moving average is $38.21. The firm has a market capitalization of $465.11 million, a P/E ratio of 24.48 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million during the quarter.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SMLR. Newbridge Financial Services Group Inc. purchased a new stake in Semler Scientific in the second quarter worth $34,000. Quest Partners LLC purchased a new stake in shares of Semler Scientific in the 2nd quarter worth about $59,000. Meeder Asset Management Inc. bought a new position in shares of Semler Scientific in the 2nd quarter worth about $67,000. US Bancorp DE lifted its position in Semler Scientific by 60.8% during the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after acquiring an additional 1,158 shares during the period. Finally, Sanctuary Advisors LLC bought a new stake in Semler Scientific during the third quarter worth about $104,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.